Antiangiogenic effects of phospholipase A2 Lys49 BnSP-7 from Bothrops pauloensis snake venom on endothelial cells: An in vitro and ex vivo approach


Butantan affiliation
Publication type
Article
Appears in Collections:
Metrics
Abstract
Antiangiogenic strategies are promising tools for cancer treatment and several other disorders. In this sense, phospholipases A2 (PLA2s) from snake venom have been described to possess antiangiogenic properties. In this study, we evaluated both in vitro and ex vivo antiangiogenic effects induced by BnSP-7, a Lys49 PLA2 isolated from Bothrops pauloensis snake venom. BnSP-7 was able to inhibit endothelial cell (HUVEC) proliferation, which was indeed confirmed by a modulation of cell cycle progression. Interestingly, BnSP-7 also inhibited the adhesion and migration of HUVECs and blocked in vitro angiogenesis in a VEGF-dependent manner, an important proangiogenic factor. Finally, BnSP-7 was capable of inhibiting sprouting angiogenic process through an ex vivo aortic ring assay. Taken together, these results indicate that BnSP-7 has potent in vitro and ex vivo antiangiogenic effect.
Reference
Polloni L, Azevedo FVPV, Teixeira SC, Moura E, Costa TR, Gimenes SNC, et al. Antiangiogenic effects of phospholipase A2 Lys49 BnSP-7 from Bothrops pauloensis snake venom on endothelial cells: An in vitro and ex vivo approach. Toxicol. In Vitro. 2021 Jan;in press:105099. doi:10.1016/j.tiv.2021.105099.
Link to cite this reference
https://repositorio.butantan.gov.br/handle/butantan/3485
Journal title
Issue Date
2021


Files in This Item:

Existing users please Login
doi.org10.1016j.tiv.2021.105099.pdf
Description: Embargo period: 12 months.
Size: 1.83 MB
Format: Adobe PDF
Embargoed until May 1, 2022    Request a copy
Show full item record

The access to the publications deposited in this repository respects the licenses from journals and publishers.